BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -75.58% | -66.15% | -31.37% | -41.82% | -15.52% |
| Gross Profit | 123.08% | 66.15% | 48.54% | -76.81% | 15.52% |
| SG&A Expenses | -40.94% | -12.04% | -29.04% | -27.66% | -14.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -66.36% | -49.99% | -30.71% | -38.08% | -15.13% |
| Operating Income | 101.22% | 49.99% | 43.03% | -22.35% | 15.13% |
| Income Before Tax | 102.42% | 58.63% | 34.26% | -49.05% | 11.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 102.42% | 58.63% | 34.26% | -49.05% | 11.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.42% | 58.63% | 34.26% | -49.05% | 11.20% |
| EBIT | 101.22% | 49.99% | 43.03% | -22.35% | 15.13% |
| EBITDA | 101.22% | 50.16% | 42.33% | -24.37% | 14.77% |
| EPS Basic | 101.70% | 67.90% | 45.41% | -22.63% | 26.82% |
| Normalized Basic EPS | 101.70% | 70.43% | 45.41% | -22.64% | 26.82% |
| EPS Diluted | 101.69% | 67.90% | 45.41% | -22.63% | 26.82% |
| Normalized Diluted EPS | 101.70% | 70.43% | 45.41% | -22.64% | 26.82% |
| Average Basic Shares Outstanding | 41.92% | 28.89% | 20.42% | 21.54% | 21.34% |
| Average Diluted Shares Outstanding | 42.01% | 28.89% | 20.42% | 21.54% | 21.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |